Financials data is unavailable for this security.
View more
Year on year Cellebrite DI Ltd had net income deteriorate from a gain of 120.81m to a loss of 81.10m despite revenues that grew 20.12% from 270.65m to 325.11m over the same period.
Gross margin | 84.19% |
---|---|
Net profit margin | -28.51% |
Operating margin | 13.85% |
Return on assets | -21.03% |
---|---|
Return on equity | -- |
Return on investment | -38.22% |
More ▼
Cash flow in USDView more
In 2023, Cellebrite DI Ltd increased its cash reserves by 116.23%, or 101.87m. The company earned 102.06m from its operations for a Cash Flow Margin of 31.39%. In addition the company generated 21.77m cash from financing while 22.54m was spent on investing.
Cash flow per share | -0.4685 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.1957 |
---|---|
Tangible book value per share | -0.3741 |
More ▼
Balance sheet in USDView more
Current ratio | 1.75 |
---|---|
Quick ratio | 1.71 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼